Moneycontrol PRO

business

Ranbaxy may bounce back to Rs 360-370: SP Tulsian

SP Tulsian of sptulsian.com feels that Ranbaxy Laboratories may bounce back to Rs 360-370 in September series itself. “There is very limited risk of going down from here and Rs 320 seems to be a good support for the stock,” he adds.

first published: Sep 17, 2013 12:17 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347